Article metrics

Extended report
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: December 2016 to October 2019

AbstractFullPdf
Dec 2016493263263
Jan 2017410273204
Feb 20173619294
Mar 2017719292
Apr 2017130088
May 20172628185
Jun 201772495202
Jul 2017217218141
Aug 2017228229102
Sep 2017176176125
Oct 201720120185
Nov 201720220480
Dec 201721021266
Jan 2018421422106
Feb 201821419383
Mar 201835734290
Apr 201830730697
May 2018234236101
Jun 201818318559
Jul 201822122172
Aug 2018259259112
Sep 201821321376
Oct 201825225288
Nov 201826726775
Dec 201819419442
Jan 201920320259
Feb 201921221271
Mar 201919419491
Apr 201914514487
May 201912512578
Jun 201910910952
Jul 201914714778
Aug 2019141140100
Sep 201913613575
Oct 201912812779
Total691782083498